TrialJournal of Korean medical science2016

A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma.

Sung Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.